Small molecule compounds targeting the p53 pathway: are we finally making progress?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small molecule compounds targeting the p53 pathway: are we finally making progress?
Authors
Keywords
p53, Small molecule compound, Wild-type, Mutant, Reactivation
Journal
APOPTOSIS
Volume 19, Issue 7, Pages 1055-1068
Publisher
Springer Nature
Online
2014-04-22
DOI
10.1007/s10495-014-0990-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression?
- (2016) Mikhail V. Blagosklonny Aging-US
- Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging
- (2016) Mikhail V. Blagosklonny Aging-US
- Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics
- (2016) Peng Zou et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Targeting TOR dependence in cancer
- (2015) Oncotarget
- A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells
- (2015) Hongbo Wang et al. NEOPLASIA
- MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
- (2013) C. Tovar et al. CANCER RESEARCH
- Metabolic Regulation by p53 Family Members
- (2013) Celia R. Berkers et al. Cell Metabolism
- TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis
- (2013) Eric C. Cheung et al. DEVELOPMENTAL CELL
- Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
- (2013) Petra Kleiblova et al. JOURNAL OF CELL BIOLOGY
- Targeting p53 by small molecules in hematological malignancies
- (2013) Manujendra N Saha et al. Journal of Hematology & Oncology
- Small molecule induced reactivation of mutant p53 in cancer cells
- (2013) Xiangrui Liu et al. NUCLEIC ACIDS RESEARCH
- Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53
- (2013) Christopher D. Wassman et al. Nature Communications
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer
- (2012) Jong-Lyel Roh et al. CANCER LETTERS
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
- (2012) Tongyuan Li et al. CELL
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy
- (2012) Razmik Mirzayans et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
- (2012) Oliver D. K. Maddocks et al. NATURE
- Adjuvant treatment of GIST: patient selection and treatment strategies
- (2012) Heikki Joensuu Nature Reviews Clinical Oncology
- Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma
- (2012) Manujendra N. Saha et al. PLoS One
- Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization
- (2012) B. Graves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
- (2011) Sophia Y. Lunt et al. Annual Review of Cell and Developmental Biology
- Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts
- (2011) Cyrus Chargari et al. CANCER LETTERS
- The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth, and chemosensitivity under hypoxic conditions
- (2011) Elizabeth M. Matthew et al. CELL CYCLE
- Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs
- (2011) Rosa Puca et al. CELL CYCLE
- A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors
- (2011) J. Tabernero et al. CLINICAL CANCER RESEARCH
- MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination
- (2011) Xinjiang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
- (2011) D. Li et al. MOLECULAR CANCER RESEARCH
- Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
- (2011) M H Aziz et al. ONCOGENE
- Initial testing of JNJ-26854165 (Serdemetan) by the pediatric preclinical testing program
- (2011) Malcolm A. Smith et al. PEDIATRIC BLOOD & CANCER
- The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
- (2011) L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA
- (2010) Carolyn Y. Zhao et al. CELL CYCLE
- Identification and Characterization of the First Small Molecule Inhibitor of MDMX
- (2010) Damon Reed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Novel Tryptamine Derivative JNJ-26854165 Induces Wild-Type p53- and E2F1-Mediated Apoptosis in Acute Myeloid and Lymphoid Leukemias
- (2010) K. Kojima et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
- (2010) K G Wiman ONCOGENE
- Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents
- (2010) Karita Peltonen et al. PLoS One
- Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
- (2010) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53 orchestra: Mdm2 and Mdmx set the tone
- (2010) Mark Wade et al. TRENDS IN CELL BIOLOGY
- Reactivation of p53: from peptides to small molecules
- (2010) Christopher J. Brown et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MI-63: A novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53
- (2009) J A Canner et al. BRITISH JOURNAL OF CANCER
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors
- (2009) Yu Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- p53 Regulation of Metabolic Pathways
- (2009) E. Gottlieb et al. Cold Spring Harbor Perspectives in Biology
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
- (2008) Sanjeev Shangary et al. Annual Review of Pharmacology and Toxicology
- p53 Activation: A Case against Sir
- (2008) Christopher L. Brooks et al. CANCER CELL
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- (2008) Sonia Lain et al. CANCER CELL
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
- (2008) Andrei V. Budanov et al. CELL
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute
- (2008) E M Michalak et al. CELL DEATH AND DIFFERENTIATION
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
- Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
- (2008) J. E. Kravchenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
- (2008) F. M. Boeckler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now